Trade SLDB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Solid Biosciences Inc. (SLDB) is trading at US$9.07, down 4.93% today as of Sep 10, 16:00 EDT. The company has a market capitalisation of US$997.19M. Over the past 52 weeks, SLDB has traded between US$3.79 and US$11.45. On Syfe you can trade SLDB with $0 commission and add it to your watchlist.
| Previous close | US$9.54 |
|---|---|
| Market cap | US$997.19M |
| 52-week range | US$3.79 – US$11.45 |
| Volume | 855.64K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Solid Biosciences Inc.
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
Year: 2018
Wedbush Adjusts PT on Solid Biosciences to $15 From $16, Maintains Outperform Rating
Aug 7, 3:02 PM · MT Newswires
Wedbush Adjusts Price Target on Solid Biosciences to $16 From $17, Maintains Outperform Rating
May 13, 1:26 PM · MT Newswires
Solid Biosciences Says SGT-003 Gets EU Orphan Drug Designation for Duchenne Muscular Dystrophy
Apr 28, 2:25 PM · MT Newswires
Guggenheim Initiates Solid Biosciences at Buy With $26 Price Target
Mar 20, 11:17 AM · MT Newswires
Solid Biosciences Inc. (SLDB) stock is trading at US$9.07, -4.93% from the previous close of US$9.54.
The market cap for Solid Biosciences Inc. (SLDB) stock is approximately US$997.19M.
The 52-week high for Solid Biosciences Inc. (SLDB) stock is US$11.45.
The 52-week low for Solid Biosciences Inc. (SLDB) stock is US$3.79.
Solid Biosciences Inc. (SLDB) does not currently pay a dividend.
Stay on top of SLDB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
